Study to characterise patients receiving benralizumab in the framework of an individualized access program in Spain

Trial Identifier: D3250R00052
Sponsor: AstraZeneca
NCTID:: NCT04126499
Start Date: January 2020
Primary Completion Date: May 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Madrid, Spain